Selected work
Many engagements are confidential. These anonymised summaries describe problem class, our role and evidence-bound outcomes — without claiming partnership with FDA or guaranteeing future agency decisions.
FDA regulatory writing — global pharmaceutical company
End-to-end plan preparation; FDA approved the plan. Client remained party of record.
Clinical trial documentation — major biopharma
Complete clinical-trial-related plan and documentation; FDA approved the plan.
Ophthalmology medical devices — FDA plan & US clearance
Complete plan, client-authorised communication with FDA inspectors; plan approved; devices cleared for the US market.
Ready to discuss a programme?
Tell us about your organisation and the type of support you need. Do not send PHI or confidential regulatory packs through the public form.